IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $216,886 | -17.4% | 20,384 | -18.3% | 0.04% | -20.4% |
| Q1 2023 | $262,569 | -41.7% | 24,959 | -31.3% | 0.05% | -54.6% |
| Q4 2022 | $450,092 | +210.4% | 36,327 | +159.8% | 0.11% | +227.3% |
| Q3 2022 | $145,000 | -71.2% | 13,984 | -68.0% | 0.03% | -75.7% |
| Q2 2022 | $504,000 | +130.1% | 43,693 | +132.2% | 0.14% | +81.3% |
| Q4 2021 | $219,000 | -28.9% | 18,816 | -20.3% | 0.08% | -25.0% |
| Q3 2021 | $308,000 | +96.2% | 23,616 | +94.1% | 0.10% | +53.8% |
| Q2 2021 | $157,000 | +6.8% | 12,166 | -5.4% | 0.06% | -27.8% |
| Q4 2020 | $147,000 | +22.5% | 12,866 | +10.2% | 0.09% | -40.8% |
| Q2 2020 | $120,000 | -51.8% | 11,676 | -13.5% | 0.15% | -10.1% |
| Q3 2018 | $249,000 | +1.6% | 13,500 | -6.1% | 0.17% | -73.3% |
| Q1 2017 | $245,000 | -41.9% | 14,383 | -58.9% | 0.63% | +75.6% |
| Q2 2015 | $422,000 | – | 34,980 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |